Creative Planning Mustang Bio, Inc. Transaction History

Creative Planning

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.35 - $0.72 $350 - $720	1,000 Added 5.0%	21,004 $7,000
Q4 2022 Feb 10, 2023	BUY	$0.32 - $8.27 $1 - $33	4 Added 0.02%	20,004 $7,000
Q3 2022 Nov 03, 2022	BUY	$0.46 - $7.2 $9,200 - $144,000	20,000 New	20,000 $9,000
Q2 2021 Aug 04, 2021	SELL	$2.7 - $3.81 $27,270 - $38,481	-10,100 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$3.02 - $5.16 $4,454 - $7,611	-1,475 Reduced 12.74%	10,100 $34,000
Q4 2020 Jan 29, 2021	BUY	$2.66 - $4.18 $30,789 - $48,383	11,575 New	11,575 $44,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $22.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.